Genvoya and Belsomra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Genvoya (cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate) and Belsomra (suvorexant). Common drug interactions include dyslipidaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Genvoya and Belsomra. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Genvoya?

Genvoya has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 13,538 Genvoya users. Check the latest studies of Genvoya.

What is Belsomra?

Belsomra has active ingredients of suvorexant. It is often used in insomnia. eHealthMe is studying from 12,961 Belsomra users. Check the latest studies of Belsomra.

On Jul, 14, 2026

14 people who take Genvoya and Belsomra together, and have interactions are studied.

What are the common drug interactions of Genvoya and Belsomra, by gender? *:

female:

n/a

male:

Dyslipidaemia (abnormal amount of lipids)
Herpes zoster
Throat irritation
Blood creatinine increased
Facial spasm (involuntary muscle contractions face)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Somnolence (a state of near-sleep, a strong desire for sleep)
Tinnitus (a ringing in the ears)
Nephrolithiasis (calculi in the kidneys)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)

What are the common drug interactions of Genvoya and Belsomra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Facial spasm (involuntary muscle contractions face)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Somnolence (a state of near-sleep, a strong desire for sleep)
Tinnitus (a ringing in the ears)

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 9 people, 64.29%
High Blood Cholesterol: 3 people, 21.43%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 14.29%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 14.29%
Pain: 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 2 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
Bacterial Infection: 2 people, 14.29%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Genvoya and Belsomra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously